Brought to you by 
GSK buys the Biotene brand for $170mm
Nov 2008
Executive Summary
GlaxoSmithKline Consumer Healthcare has agreed to purchase the Biotene line of dry mouth products from Laclede for $170mm.
Deal Industry
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Product Purchase
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK buys the Biotene brand for $170mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice